Research on the Multisectoral Impact of Infectious Diseases on the Economy | Journal of Pharmaceutic

The aim of the work is to recognize the characteristics of the multidimensional effect of infectious disease spread on countries' economic growth. The author concludes that the public health exposure mechanism to regional or global emerging and endemic infectious diseases may have wider socio-economic ramifications that are often not taken into account for risk or impact assessment purposes. Such events can trigger economic shocks with the spread of foreign travel and trade that go far beyond the conventional health sectors and the pathogen's original geographical range.

Accompanied by the markets and rising economic globalization, intense economic specialization and a wider division of labor increase the likelihood of people coming into contact with sources that lead to highly infectious diseases including influenza and COVID-19. Taking into account the high degree of interdependence of economic activities in the modern economy, the adverse economic effects of new forms or types of these diseases can be severe. The absence of workers from work due to such infections, for instance, or the risks of such infections may interrupt production at the level of the workplace. These pandemics can often interrupt or disrupt supply chains and, moreover, they typically have a negative effect on overall demand for products. The COVID-19 epidemic, which contributed to a severe global economic crisis, is evidence of this. The frequency of epidemics and pandemics and their effects rely on the existence and stages of economic growth. Modern society's economic and social structure contributes to the transmission of diseases based on human contact or presence, especially those caused by airborne microbes or that persist on widely used surfaces.

The study concluded that local, national and international public and private stakeholders should work together to tackle the economic implications of infectious diseases, to provide informed structures and risk and effect analysis, and to encourage, where possible, cost-sharing mechanisms for prevention and preparedness, and to assess, where appropriate, optimal intervention strategies. In today's globalized world, innovations related to infectious diseases need increased responsibility for protecting the health and economic welfare of citizens.

Please see the link :- https://www.journaljpri.com/index.php/JPRI/article/view/30855